as on March 11, 2026 at 6:59 am IST
Day's Low
Day's High
6.35%
Downside
0.57%
Upside
52 Week's Low
52 Week's High
73.52%
Downside
7.54%
Upside
Check Arcus Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.9B
EPS (TTM)
-4.15
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.36
Industry PE ratio
-3.0743525179856115
PEG Ratio
0EBITDA
-376.0M
Revenue (TTM)
247.0M
Profit Margin
-142.92%
Return On Equity TTM
-63.26%
Track how Arcus Biosciences Inc P/E has moved over time to understand its valuation trends.
Arcus Biosciences Inc in the last 5 years
Lowest (-12.43x)
March 31, 2021
Today (-6.36x)
March 11, 2026
Industry (-3.07x)
March 11, 2026
Highest (90.21x)
December 31, 2021
Today’s Price to Earnings Ratio: -6.36x
Compare market cap, revenue, PE, and other key metrics of Arcus Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.9B | -37.04% | -6.36 | -142.92% | |
| BUY | $42.9B | 125.47% | 138.88 | 8.45% | |
| BUY | $117.1B | 132.01% | 30.12 | 32.94% | |
| NA | $34.9B | NA | 121.89 | 5.37% | |
| BUY | $82.6B | 64.28% | 18.83 | 31.41% |
The Arcus Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Arcus Biosciences Inc investment value today
Current value as on today
₹2,53,172
Returns
₹1,53,172
(+153.17%)
Returns from Arcus Biosciences Inc Stock
₹1,47,980 (+147.98%)
Dollar Returns*
₹5,192 (+5.19%)
Based on 18 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 18 analysts, 83.33% of analysts recommend a 'BUY' rating for Arcus Biosciences Inc. Average target price of $33.8
Get share price movements and forecasts by analysts on Arcus Biosciences Inc.
What analysts predicted
27.37%UPSIDE
Target Price
$33.8
Current Price
$24.55
Analyzed by
18 Analysts
Target
$33.80
Arcus Biosciences Inc target price $33.8, a slight upside of 27.37% compared to current price of $24.55. According to 18 analysts rating.
Search interest for Arcus Biosciences Inc Stock has increased by 809% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:809% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -135.0M → -98.0M (in $), with an average increase of 37.8% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 26.0M → 33.0M (in $), with an average increase of 21.2% per quarter
Price Rise
![]()
In the last 6 months, RCUS stock has moved up by 103.7%
Best in 1 Year
![]()
In the last 1 year, RCUS has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.2% return, outperforming this stock by 35.6%
| Organisation | Arcus Biosciences Inc |
| Headquarters | 3928 Point Eden Way, Hayward, CA, United States, 94545 |
| Industry | Health Technology |
| CEO | Dr. Terry J. Rosen Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Juan Carlos Jaen Ph.D. | Co- Founder & President |
Dr. K. Christopher Garcia Ph.D. | Co-Founder & Member of Scientific Advisory Board |
Dr. Jonathan Yingling Ph.D. | Chief Scientific Officer |
Dr. Terry J. Rosen Ph.D. | Co-Founder, Chairman & CEO |
Ms. Jennifer A. Jarrett M.B.A. | Chief Operating Officer |
Mr. Alexander Azoy CPA | VP of Finance & Principal Accounting Officer |
Pia Eaves | Vice President of Investor Relations & Strategy |
Ms. Carolyn C. Tang J.D. | General Counsel & Corporate Secretary |
Holli Kolkey | Vice President of Corporate Communications |
Mr. Robert C. Goeltz II | Principal Financial Officer & CFO |
Arcus Biosciences Inc share price today is $24.55 as on at the close of the market. Arcus Biosciences Inc share today touched a day high of $24.69 and a low of $22.99.
Arcus Biosciences Inc share touched a 52 week high of $26.4 on and a 52 week low of $6.5 on . Arcus Biosciences Inc stock price today i.e. is closed at $24.55,which is 7.01% down from its 52 week high and 277.69% up from its 52 week low.
Arcus Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Arcus Biosciences Inc (RCUS) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Arcus Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arcus Biosciences Inc share’s latest price of $24.55 as on March 11, 2026 at 1:29 am IST, you will get 0.4073 shares of Arcus Biosciences Inc. Learn more about
fractional shares .
Arcus Biosciences Inc stock has given -37.04% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?